No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Akira Sawa, M.D., Ph.D., expert on schizophrenia research
Akira Sawa, M.D., Ph.D.
April 07, 2014
In new research led by 2011 NARSAD Distinguished Investigator Grantee Akira Sawa, M.D., Ph.D., an experimental anticancer medication has been found to reverse...
Francis S. Lee, M.D., Ph.D., expert on post-traumatic stress disorder (PTSD)
Francis S. Lee, M.D., Ph.D.
April 04, 2014
2010 NARSAD Independent Investigator Grantee Francis S. Lee, M.D., Ph.D., of Weill Cornell Medical College, served on a multi-institutional research team for a...
Tomas G. M. Hokfelt, M.D., Ph.D. - Brain and behavior research expert on depression
Tomas G. M. Hokfelt, M.D., Ph.D.
April 02, 2014
An international team has discovered that a brain chemical not previously linked to depression, called galanin, plays an important role in determining who is...
The Wall Street Journal
March 28, 2014
The Wall Street Journal on March 28th published a headline article “Companies Find Autism Can Be a Job Skill.” The article was introduced with the statement “...
Fang Liu, M.D., Ph.D., expert in depression research
Fang Liu, M.D., Ph.D.
March 28, 2014
The World Health Organization (WHO) estimates that more than 350 million people suffer from depression worldwide. New research, as reported online in...

Pages

Subscribe to